Leon Kircik (L Kircik)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Atopic Dermatitis

Coronary Artery Disease

Top Venues

Dermatology and therapy

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Eric L Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F Eichenfield
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies. Dermatology and therapy 14 (8) (2024)
Eric L Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F Eichenfield
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies. Dermatology and therapy 14 (8) (2024)
Eric L Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F Eichenfield
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies. Dermatology and therapy (2024)
Eric L Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F Eichenfield
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies. Dermatology and therapy 14 (8) (2024)
Leon Kircik, Matthew Zirwas, Shawn G Kwatra, G Michael Lewitt, Holly Glover, Tomas Chao, Philip M Brown, David S Rubenstein, Anna M Tallman
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis. Dermatology and therapy 14 (1) (2023)
Leon Kircik, Matthew Zirwas, Shawn G Kwatra, G Michael Lewitt, Holly Glover, Tomas Chao, Philip M Brown, David S Rubenstein, Anna M Tallman
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis. Dermatology and therapy 14 (1) (2023)
Leon Kircik, Matthew Zirwas, Shawn G Kwatra, G Michael Lewitt, Holly Glover, Tomas Chao, Philip M Brown, David S Rubenstein, Anna M Tallman
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis. Dermatology and therapy (2023)
Leon Kircik, Matthew Zirwas, Shawn G Kwatra, G Michael Lewitt, Holly Glover, Tomas Chao, Philip M Brown, David S Rubenstein, Anna M Tallman
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis. Dermatology and therapy 14 (1) (2023)
Leon Kircik, Matthew Zirwas, Shawn G Kwatra, G Michael Lewitt, Holly Glover, Tomas Chao, Philip M Brown, David S Rubenstein, Anna M Tallman
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis. Dermatology and therapy 14 (1) (2023)
Andreas Wollenberg, Andrew Blauvelt, Emma Guttman-Yassky, Margitta Worm, C Lynde, Jean-Philippe Lacour, Lynda Spelman, Norito Katoh, Hidehisa Saeki, Y Poulin, A Lesiak, Leon Kircik, S H Cho, Pedro Herranz Pinto, Michael J Cork, Ketty Peris, L A Steffensen, B Bang, A Kuznetsova, T N Jensen, M L Østerdal, E L Simpson, null null
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2). The British journal of dermatology 184 (3) (2020)